Vagal nerve stimulation: Overview and implications for anesthesiologists

Anesthesia and Analgesia

Volumn 103, Issue 5, 2006, Pages 1241-1249

  Hatton, Kevin W ^a,b   McLarney, J Thomas ^a   Pittman, Thomas ^a   Fahy, Brenda G ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; COUGHING; DYSPEPSIA; DYSPNEA; ELECTROSTIMULATION; EPILEPSY; FEVER; HEADACHE; HUMAN; INFECTION; MEDICAL SPECIALIST; NAUSEA; PAIN; PARESTHESIA; PHARYNGITIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VAGUS NERVE; VAGUS NERVE STIMULATION; VOICE CHANGE; VOMITING;

EID: 33750339118     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000244532.71743.c6     Document Type: Review

References (69)

1. McLachlan, RS. Vagus nerve stimulation for intractable epilepsy: a review. J Clin Neurophysiol 1997;14:358-68.
2. Guberman A. Vagus nerve stimulation in the treatment of epilepsy. Can Med Assoc J 2004;171:1165-6.
3. Zanchetti A, Wang SC, Moruzzi G. The effect of vagal afferent stimulation on the EEG pattern of the cat. Electroencephalogr Clin Neurophysiol 1952;4:357-61.
4. Chase MH, Sterman MB, Clemente CD. Cortical and subcortical patterns of response to afferent vagal stimulation. Exp Neurol 1966;16:36-49.
5. Penry JK, Dean JC. Prevention of intractable partial seizures by intermittent vagal stimulation in humans: preliminary results. Epilepsia 1990;31:S40-3.
6. Handforth A, DeGiorgio CM, Schachter SC, et al. Vagus nerve stimulation therapy for partial-onset seizures: a randomized active-control trial. Neurology 1998;51:48-55.
7. Cohen-Gadol AA, Britton JW, Wetjen NM, et al. Neurostimulation therapy for epilepsy: current modalities and future directions. Mayo Clin Proc 2003;78:238-48.
8. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, et al. Vagus nerve stimulation for treatment of partial seizures. I. A controlled study of effect on seizures. Epilepsia 1994;35:616-26.
9. DeGirogio CM, Schachter SC, Handforth A, et al. Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizures. Epilepsia 2000;41:1195-200.
10. Physician's Manual VNS Therapy™ Pulse Model 102 Generator and VNS Therapy™ Pulse Duo Model 102R Generator, May 2003, U.S. Domestic Version. Houston, TX: Cyberonics, 2004. Available at http://www.vnstherapy.com/manuals/ doc_download.asp?docid={E5D2100B-A4C2-409B-B71C-E1CEA60FBD90}.
11. Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology 2002;59:S3-14.
12. Foley JO, DuBois F. Quantitative studies of the vagus nerve in the cat. I. The ratio of sensory to motor fibers. J Comp Neurol 1937;67:49-67.
13. Brodal A. Nueurological anatomy in relation to clinical medicine. 3rd ed. New York: Oxford University Press, 1981.
14. Rutecki P. Anatomical, physiological, and theoretical basis for the antiepileptic effect of vagus nerve stimulation. Epilepsia 1990;31:S1-6.
15. Ricardo JA, Koh ET. Anatomical evidence of direct projections from the nucleus of the solitary tract to the hypothalamus, amygdale, and other forebrain structures in the rat. Brain Res 1978;153:1-26.
16. Morest DK. Experimental study of the projections of the nucleus of the tractus solitarius and the area postrema in the cat. J Comp Neurol 1967;130:277-300.
17. Cecheto DF. Central representation of visceral function. Fed Proc 1987;46:17-23.
18. Saper CB, Kibbe MR, Hurley KM, et al. Brain natriuretic peptide-like immunoreactive innervation of the cardiovascular and cerebrovascular systems in the rat. Circ Res 1990;67:1345-54.
19. Roizen MF, Fleisher LA. Anesthetic implications of concurrent diseases. In: Miller RD, ed. Miller's anesthesia. 6th ed. Philadelphia, PA: Elsevier, Churchill Livingstone, 2005:1017-149.
20. Kofke WA, Tempelhoff R, Dasheiff RM. Anesthetic implications of epilepsy, status epilepticus, and epilepsy surgery. J Neurosurg Anesthesiol 1997;9:349-72.
21. Modica PA, Tempelhoff R, White PF. Pro- and anti-convulsant effects of anesthetics (Part II). Anesth Analg 1990;70:433-44.
22. Kim CS, Arnold FJ, Itani MS, et al. Decreased sensitivity to metocurine during long term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology 1992;77:500-6.
23. Melton AT, Antognini JF, Gronert GA. Prolonged duration of succinylcholine in patients receiving anticonvulsants: evidence for mild upregulation of acetylcholine receptors? Can J Anaesth 1993;40:939-42.
24. Modica PA, Tempelhoff R, White PF. Pro- and anti-convulsant effects of anesthetics (Part I). Anesth Analg 1990;70:303-15.
25. Kiersey DK, Bickford RG, Faulconer A. Electroencephalographic patterns produced by thiopental sodium during surgical operations: description and classification. Br J Anaesth 1951;23:141-52.
26. Stefan H, Sonntag H, Schenk HD, Kohlhausen S. Effects of Disoprivan (propofol) on cerebral blood flow, cerebral oxygen consumption, and cerebral vascular reactivity. Anaesthesist 1987;36:60-5.
27. Ferrer-Allado T, Brechner VL, Dymond A, et al. Ketamine-induced electroconvulsive phenomena in the human limbic and thalamic regions. Anesthesiology 1973;38:333-44.
28. Bennett DR, Madsen JA, Jordan WS, Wiser WC. Ketamine anesthesia in brain-damaged epileptics: electroencephalographic and clinical observations. Neurology 1973;23:449-60.
29. Carlsson C, Smith DS, Keykhah MM, et al. The effects of high-dose fentanyl on cerebral circulation and metabolism in rats. Anesthesiology 1982;57:375-80.
30. Tommasino C, Maekawa Y, Shapiro HM, et al. Fentanyl-induced seizures activate subcortical brain metabolism. Anesthesiology 1984;60:283-90.
31. Young ML, Smith DS, Greenberg J, et al. Effects of sufentanil on regional cerebral glucose utilization in rats. Anesthesiology 1984;61:564-8.
32. Kofke WA, Attaallah AF, Kuwabara H, et al. The neuropathologic effects in rats and neurometabolic effects in humans of large-dose remifentanil. Anesth Analg 2002;94:1229-36.
33. Kearse LA Jr, Koski G, Husain MV, et al. Epileptiform activity during opioid anesthesia. Electroencephalogr Clin Neurophysiol 1993;87:347-9.
34. Ross J, Kearse LA Jr, Barlow MK, et al. Alfentanil-induced epileptiform activity: a simultaneous surface and depth electroencephalographic study in complex partial epilepsy. Epilepsia 2001;42:220-5.
35. Iijima T, Nakamura Z, Iwao Y, et al. The epileptogenic properties of the volatile anesthetics sevoflurane and isoflurane in patients with epilepsy. Anesth Analg 2000;91:989-95.
36. Vakkuri A, Yli-Hankala A, Sarkela M, et al. Sevoflurane mask induction of anaesthesia is associated with epileptiform EEG in children. Acta Anaesthesiol Scand 2001;45:805-11.
37. YLi-Hankala A, Vakkuri A, Sarkela M, et al. Epileptiform electroencephalogram during mask induction of anesthesia with sevoflurane. Anesthesiology 1999;91:1596-603.
38. Jääskeläinen SK, Kaisti K, Suni S, et al. Sevoflurane is epileptogenic in healthy subjects at surgical levels of anesthesia. Neurology 2003;61:1073-8.
39. Kurita N, Kawaguchi M, Hoshida T, et al. The effects of sevoflurane and hyperventilation on electrocorticogram spike activity in patients with refractory epilepsy. Anesth Analg 2005;101:517-23.
40. Lebowitz MH, Blitt CD, Dillon JB. Clinical investigation of compound 347 (ethrane). Anesth Analg 1970;49:1-10.
41. Bart AJ, Homi J, Linde HW. Changes in power spectra of electroencephalograms during anesthesia with fluroxene, methoxyflurane, and ethrane. Anesth Analg 1971;50:53-63.
42. American Society of Anesthesiologists. The standards for basic anesthetic monitoring page. Available at http://www.asahq.org/publicationsAndServices/ standards/02.pdf. Accessed May 1, 2006.
43. American Society of Anesthesiologists Task Force on Intraoperative Awareness. Practice advisory for intraoperative awareness and brain function monitoring: a report by the American Society of Anesthesiologists task force on intraoperative awareness. Anesthesiology 2006;104:847-64.
44. Ramsay RE, Uthman BM, Augustinsson LE, et al. Vagus nerve stimulation for treatment of partial seizures. II. Safety, side effects, and tolerability. Epilepsia 1994;35:627-36.
45. Frei MG, Osorio I. Left vagus nerve stimulation with the neurocybernetic prosthesis has complex effects on heart rate and on its variability in humans. Epilepsia 2001;42:1007-16.
46. Tatum WO, Moore DB, Stecker MM, et al. Ventricular asystole during vagus nerve stimulation for epilepsy in humans. Neurology 1999;52:1267.
47. Asconape JJ, Moore DD, Zipes DP, et al. Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: a rare complication of intraoperative device testing. Epilepsia 1999;40:1452-4.
48. McLachlan RS. Suppression of interictal spikes and seizures by stimulation of the vagus nerve. Epilepsia 1993;34:918-23.
49. Banzett RB, Guz A, Paydarfar D, et al. Cardiorespiratory variables and sensation during stimulation of the left vagus in patients with epilepsy. Epilepsy Res 1999;35:1-11.
50. Malow BA, Edwards J, Marzec M, et al. Effects of vagus nerve stimulation on respiration during sleep. Neurology 2000;55:1450-4.
51. Malow BA, Levy K, Maturen K, Bowes R. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology 2000;55:1002-7.
52. Marzec M, Edwards J, Sagher O, et al. Effects of vagus nerve stimulation on sleep-related breathing in epilepsy patients. Epilepsia 2003;44:930-5.
53. Schachter S, Saper C. Vagus nerve stimulation. Epilepsia 1998;39:677-86.
54. Lee LH, Friedman DB, Lydic R. Respiratory nuclei share synaptic connectivity with pontine reticular regions regulating REM sleep. Am J Physiol 1995;268:L251-62.
55. Lydic R. Respiratory modulation by nonrespiratory neurons. In: Schwartz W, ed. Sleep science: integrating basic research and clinical practice. Basel: Karger, 1997;117-142.
56. American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Obstructive Sleep Apnea. Practice guidelines for the perioperative management of patients with obstructive sleep apnea: a report by the American Society of Anesthesiologists task force on perioperative management of patients with obstructive sleep apnea. Anesthesiology 2006;104:1081-93.
57. Zumsteg D, Jenny D, Wieser HG. Vocal cord adduction during vagus nerve stimulation for treatment of epilepsy. Neurology 2000;54:1388-9.
58. Zalvan C, Sulica L, Wolf S, et al. Laryngopharyngeal dysfunction from the implant vagal nerve stimulator. Laryngoscope 2003;113:221-5.
59. Bernards CM. An unusual cause of airway obstruction during general anesthesia with a laryngeal mask airway. Anesthesiology 2004;100:1017-8.
60. Sanossian N, Haut S. Chronic diarrhea associated with vagal nerve stimulation. Neurology 2002;58:330.
61. Hoppe C, Helmstaedter C, Scherrmann J, et al. Self-reported mood changes following 6 months of vagus nerve stimulation in epilepsy patients. Epilepsy Behav 2001;2:334-42.
62. Rush AJ, George MS, Sackeim HA, et al. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 2000;47:276-86.
63. Sackeim HA, Rush AJ, George MS, et al. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 2001;25:713-28.
64. George MS, Nahas Z, Bohning DE, et al. Vagus nerve stimulation therapy: a research update. Neurology 2002;59:56-61.
65. Sobocki J, Krolczyk G, Herman RM, et al. Influence of vagal nerve stimulation on food intake and body weight - results of experimental studies. J Physiol Pharmacol 2005;56:S27-33.
66. Ren K, Randich A, Gebhart GF. Vagal afferent modulation of a nociceptive reflex in rats: involvement of spinal opioid and monoamine receptors. Brain Res 1988;446:285-94.
67. Ren K, Randich A, Gebhart GF. Effects of electrical stimulation of vagal afferents on spinothalamic tract cells in the rat. Pain 1991;44:311-9.
68. Guarini S, Altavilla D, Cainazzo MM, et al. Efferent vagal fibre stimulation blunts nuclear factor-κ-B activation and protects against hypovolemic hemorrhagic shock. Circulation 2003;107:1189-94.
69. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000;405:458-62.